Bladder Tumors and other Topics in Urological Oncology

Front Matter....Pages i-xvi
Front Matter....Pages 1-1
TNM Classification of Urological Tumours — 1978 Edition....Pages 3-6
T Category in Renal Carcinoma....Pages 7-8
TNM Classification of Urinary Bladder Tumours: Value of Ta Category for Non Infiltrating Exophytic Tumours....Pages 9-12
Prednimustine....Pages 13-19
Orgotein Efficacy in Ameliorating Side Effects Due to Radiation Therapy....Pages 21-26
Metronidazole: A Radiosensitiser of the Hypoxic Cells....Pages 27-29
Cis-Diammine-Dichloro-Platinum Single Drug and Combination Chemotherapy in the Treatment of Genitourinary Cancer....Pages 31-34
The Aims and Activities of the EORTC Urological Group....Pages 35-39
WHO Collaborating Centre for Research and Treatment of Urinary Bladder and Prostatic Carcinoma....Pages 41-43
Front Matter....Pages 45-45
Chemical Carcinogenesis — A Review and Personal Observations with Special Reference to the Role of Tobacco and Phenacetin in the Production of Urothelial Tumours....Pages 47-54
Pathology of Bladder Tumours. The Urologist’s Point of View....Pages 55-58
Newer Aspects of Research in the Field of Bladder Tumours....Pages 59-67
Cytology of Bladder Tumours — Round Table....Pages 69-75
Scanning and Transmission Electron Microscopy of Hyperplastic and Neoplastic Human Urothelium....Pages 77-81
In Situ Carcinoma of the Bladder....Pages 83-86
Primary and Secondary Carcinoma-In-Situ....Pages 87-89
Computed Tomography of Bladder Tumours....Pages 91-96
Transrectal Ultrasonography: Staging of Bladder Tumours....Pages 97-99
Lymphangiography in Advanced Bladder Cancer....Pages 101-102
Clinical Significance of Urinary CEA Estimations in the Follow-Up of Patients with Bladder Carcinoma....Pages 103-104
Front Matter....Pages 45-45
Glycosaminoglycans (GAG) In the Normal and Neoplastic Urinary Bladder - Preliminary Results....Pages 105-106
Collagenase Activity in Human Bladder Cancers....Pages 107-111
The Copenhagen Bladder Cancer Project 1968–1974....Pages 113-116
Factors Influencing Prognosis in Patients with Bladder Tumours....Pages 117-119
Urinary Tract Infection in Patients with Bladder Tumor....Pages 121-122
Adenocarcinoma of the Bladder....Pages 123-130
Introduction to Immunology and Immunotherapy of Bladder Tumours....Pages 131-134
Immune Response in Bladder Cancer....Pages 135-148
Monocyte Function in Bladder Cancer....Pages 149-154
T and B Lymphocytes in Patients with Bladder Tumours....Pages 155-156
ABH-Antigenicity in T1 Urothelial Tumours....Pages 157-160
Humoral and Cellular Immune Response in Patients with Transitional Cell Carcinoma of the Urinary Bladder (TCC) Against Bladder Carcinoma Cells in Tissue Culture....Pages 161-164
Immunotherapy in Bladder Cancer....Pages 165-170
Intravesical BCG (Bacillus Calmette-Guerin) In the Management of T1 Nx Mx Transitional Cell Tumours of the Bladder: A Toxicity Study....Pages 171-174
BCG Vaccine in the Treatment of Non Infiltrating Papillary Tumours of the Bladder....Pages 175-186
Transurethral Surgery....Pages 187-191
Transurethral Resection or Cystectomy? An Attempt to Answer this Question by an Evaluation of 688 Patients with Carcinoma of the Bladder (with Special Reference to Age, Sex, Stage and the presence of Associated Disease)....Pages 193-200
Partial Cystectomy....Pages 201-205
Autologous Human Skin Flaps in Partial Replacement of the Bladder Wall....Pages 207-210
Indications for Cystectomy....Pages 211-214
Front Matter....Pages 45-45
The Results of Total Cystectomy for Carcinoma of the Bladder....Pages 215-218
Radical Cystectomy in Advanced Bladder Tumours....Pages 219-220
Cancer of the Urethra Following Cystectomy....Pages 221-223
Supravesical Urinary Diversion....Pages 225-242
Treatment of the Cancer of the Bladder by Irradiation, Cystoprostatectomy and Ileocystoplasty....Pages 243-245
A Type of Rectal Pouch for Urinary Diversion after Cystectomy....Pages 247-250
Comparison of Bricker and Wallace Methods of Ureteroileal Anastomosis in Urinary Diversion....Pages 251-252
Lymphadenectomy in Bladder Cancer....Pages 253-257
Effects of Intravesical Formaldehyde-Instillation (Experimental and Clinical Results)....Pages 259-264
Hydrostatic Pressure Technique and Intravesical Instillation of Formalin: Methods for the Control of Severe Bleeding from the Bladder....Pages 265-266
Intravesical Hyperthermia for Transitional Cell Carcinoma of the Bladder....Pages 267-270
Hyperthermia and Bladder Cancer....Pages 271-277
Radiotherapy in the Management of Bladder Carcinoma....Pages 279-280
Carcinoma of the Bladder Category T3 Nx, 0–4 MO Treated By Pre-Operative Irradiation Followed by Cystectomy at the Rotterdam Radiotherapy Institute....Pages 281-282
Surgical Treatment of 81 Deep Infiltrating Bladder Tumours after Preoperative Irradiation....Pages 283-285
Cystectomy Following Full Course Irradiation....Pages 287-289
Complications of Irradiation of Urological Tumours....Pages 291-298
Post-Diversion, Pre-Cystectomy Irradiation for Transitional Cell Carcinoma of the Bladder....Pages 299-303
Treatment of Malignant Tumours of the Bladder by Iridium 192 Wiring....Pages 305-309
Carcinoma of the Urinary Bladder Treated by Interstitial Radium Implant....Pages 311-312
Front Matter....Pages 45-45
Radioactive Source Implantation in Bladder Tumours....Pages 313-315
Intravesical Treatment of Superficial Urinary Bladder Tumours with Adriamycin....Pages 317-320
Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumours....Pages 321-322
Local Treatment of Uroepithelial Bladder Tumours with Adriamycin....Pages 323-326
Adriamycin Therapy in Carcinoma in Situ: A Preliminary Report....Pages 327-328
Bladder Instillation of Adriamycin in Multiple Recurrent Non-Invasive Papillomatous Bladder Tumours....Pages 329-331
Survival in Patients Treated with Epodyl (1968–1978)....Pages 333-334
Long-Term Intracavitary Epodyl® in Multiple or Extensive Papillary Tumours of the Urinary Bladder....Pages 335-336
Treatment of Multiple Non-Invasive Bladder Tumours with Intravesical Epodyl®....Pages 337-342
The Treatment of Single and Multiple Papillary Tumours of the Bladder (Ta/T1 NX MO)....Pages 343-346
Adjuvant Therapy of T1 Bladder Carcinoma : Preliminary Results of an EORTC Randomised Study....Pages 347-354
Intravesical Cis-Platinum in Bladder Tumours: Toxicity Study....Pages 355-359
The Treatment of Bladder Cancer with Vitamin A....Pages 361-362
The Veterans Administration Study of Chemoprophylaxis for Recurrent Stage I Bladder Tumours: Comparisons of Placebo, Pyridoxine and Topical Thiotepa....Pages 363-370
Flat Carcinoma In-Situ of the Bladder Treated by Systemic Cyclophosphamide — A Preliminary Report....Pages 371-376
Methotrexate Therapy for Multiple T1 Category Bladder Carcinoma....Pages 377-380
The Place of Chemotherapy in the Treatment of Patients with Invasive Carcinoma of the Bladder....Pages 381-385
Chemotherapy in the Treatment of Invasive Bladder Cancer....Pages 387-390
5-Fluorouracil and Adriamycin in Locally Recurrent and/or Metastatic Bladder Cancer....Pages 391-394
Adjuvant Chemotherapy Following Primary Irradiation in T3 Bladder Cancer....Pages 395-397
Front Matter....Pages 45-45
5-Fluorouracil in the Treatment of Recurrent Cancer of the Urinary Bladder....Pages 399-400
Radiotherapy, Chemotherapy and Immunotherapy for Carcinoma of the Bladder....Pages 401-404
Integrated Therapy for Invasive Bladder Carcinoma....Pages 405-422
Cancer Chemotherapy, With Special Emphasis on the Role and Influence of Clinical Trials....Pages 423-428
Front Matter....Pages 429-429
Oestrogen — Androgen Balance in Human Breast and Prostate Cancer....Pages 431-441
Steroid Receptors in Human Prostatic Tissue....Pages 443-445
Hormonal Receptors in Human Prostate: A Computerised Study of Normal and Pathological Tissue Samples....Pages 447-451
Androgen Receptors in Prostatic Cancer....Pages 453-457
Transrectal Aspiration Biopsy of the Prostate with Franzen’s Instrument....Pages 459-461
Treatment of Prostatic Cancer with Medroxyprogesterone-Acetate (MPA)....Pages 463-465
External Irradiation of Prostatic Cancer and Indicators for Failure of Treatment....Pages 467-468
Intraurethral Irradiation of Prostatic Cancer Using Afterloading Technique....Pages 469-470
Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II Tumours....Pages 471-492
Estracyt....Pages 493-500
Front Matter....Pages 501-501
Combined Treatment with Bleomycin in Penile Carcinoma....Pages 503-504
Association of Surgery and Chemotherapy in Metastatic Testicular Cancer....Pages 505-514
Back Matter....Pages 515-528